VIGIL NEUROSCIENCE INC (VIGL) Stock Price, Quote, News and Overview
NASDAQ:VIGL - Nasdaq - US92673K1088 - Common Stock - Currency: USD
VIGL Quote, Performance and Key Statistics
VIGIL NEUROSCIENCE INC
NASDAQ:VIGL (1/23/2025, 4:32:35 PM)
After market: 2.28 -0.07 (-2.98%)2.35
+0.32 (+15.76%)
The current stock price of VIGL is 2.35 USD. In the past month the price increased by 22.29%. In the past year, price decreased by -31.88%.
VIGL Latest News, Press Releases and Analysis
Curious about the stocks that are showing activity before the opening bell on Thursday?
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Vigil Neuroscience's Alzheimer's Candidate Shows Encouraging Safety Profile, Plans To Start Mid-Stage Study In Q3
Vigil Neuroscience's VG-3927 Phase 1 trial shows strong safety, 50% sTREM2 reduction, and potential Alzheimer's treatment; Phase 2 begins Q3 2025.
Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 for the Potential Treatment of Alzheimer’s Disease
Vigil Neuroscience Reports Positive Data from its Phase 1 Clinical Trial Evaluating VG-3927 for the Potential Treatment of Alzheimer’s Disease
- Safety, tolerability, pharmacokinetic, and pharmacodynamic profile supports continued development of VG-3927 as potential once-daily oral therapy for...
Vigil Neuroscience Highlights 2024 Corporate Achievements and Upcoming 2025 Milestones
VIGL Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.88 | 301.60B | ||
| AMGN | AMGEN INC | 14.46 | 149.37B | ||
| GILD | GILEAD SCIENCES INC | 20.98 | 115.80B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 862.22 | 113.24B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.29 | 76.33B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.00B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.54B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.43B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.66B | ||
| NTRA | NATERA INC | N/A | 22.68B | ||
| BIIB | BIOGEN INC | 8.8 | 20.94B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 18.18B |
Related screens
About VIGL
Company Profile
Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. The company is headquartered in Watertown, Massachusetts and currently employs 66 full-time employees. The company went IPO on 2022-01-07. The firm is focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. The company is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in its efforts to develop precision-based therapies to improve the lives of patients and their families. Its lead clinical candidate, VGL101 (iluzanebart), is a fully human monoclonal antibody TREM2 agonist that is being studied in a Phase 2 proof-of-concept trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. The firm is also developing VG-3927, its orally available small molecule TREM2 agonist program to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer’s disease in genetically defined subpopulations.
Company Info
VIGIL NEUROSCIENCE INC
100 Forge Road, Suite 700
Watertown MASSACHUSETTS US
Employees: 66
Company Website: https://www.vigilneuro.com/
Investor Relations: http://investors.vigilneuro.com
Phone: 18572544445
VIGL FAQ
What is the price of VIGL?
The current price of VIGL is 2.35 USD.
What is the symbol for VIGIL NEUROSCIENCE INC?
The exchange symbol of VIGIL NEUROSCIENCE INC is VIGL and it is listed on the Nasdaq exchange.
On which exchange is VIGL listed?
VIGL is listed on the Nasdaq exchange.
Is VIGL a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for VIGL, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of VIGL.
Does VIGL pay dividends?
VIGL does not pay a dividend.
What is the Price/Earnings (PE) ratio of VIGL?
VIGL does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.06).
What is the Short Interest ratio of VIGL?
The outstanding short interest for VIGL is 2.18% of its float.
VIGL Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to VIGL. When comparing the yearly performance of all stocks, VIGL is a bad performer in the overall market: 93.33% of all stocks are doing better.
VIGL Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VIGL. VIGL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
VIGL Financial Highlights
Over the last trailing twelve months VIGL reported a non-GAAP Earnings per Share(EPS) of -2.06. The EPS increased by -0.98% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -62.92% | ||
| ROE | -93.28% | ||
| Debt/Equity | 0 |
VIGL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 85% to VIGL. The Buy consensus is the average rating of analysts ratings from 15 analysts.